New leader for B.C. Cancer is a renowned oncologist and researcher
Local oncologist will head the B.C. Cancer agency after the last leader left early
June 19, 2019 | By Pamela Fayerman| Vancouver Sun |
.
Dr. Kim
Nguyen Chi, a respected prostate cancer researcher and oncologist, will take over as head of B.C. Cancer on July 1.
He is the first visible minority leader since the agency was established 45 years ago. Chi, who earned his medical degree at the University of Ottawa, succeeds Dr. Malcolm Moore, who announced four months ago that he would be leaving the post about a year early.
Arbutus receives regulatory clearance to initiate Phase 1a/1b Clinical Trial of AB-729
June 20, 2019 | Globe Newswire |
WARMINSTER, Pa. |
Arbutus Biopharma Corporation
(Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced it has received regulatory clearance to initiate a Phase 1a/1b clinical trial of AB-729, Arbutus' subcutaneously-administered RNA interference (RNAi) agent.
Arbutus Appoints William Collier as Next President & CEO and Announces Retirement of Current President & CEO, Mark J. Murray Ph.D.
June 17, 2019 | WARMINSTER, Pa.
, | (GLOBE NEWSWIRE) -
Arbutus Biopharma Corporation
(Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced the appointment of
William H. Collier
as President and Chief Executive Officer, effective
June 24th
.
Financial Support for Canadian Medtech Companies to Attend AdvaMed MedTech Conference in Boston
From September 23-25, 2019, more than 3,000 of the world's top medtech executives will gather in Boston, MA, for the leading event in our industry.
Ten (10) Canadian medtech companies can receive financial support from Medtech Canada (up to 75% of eligible expenses) to attend the conference.
Application Submission Deadline: June 21, 2019 (12 noon) Please submit the information via email to: Katharine Ashford-Smith at: Kashford-Smith@medtechcanada.org
adMare BioInnovations Appoints Dr. Youssef Bennani as Venture Partner
SCN Launches Funding Competition to Support
Translational Stem Cell Research Across Canada
industry
NEWS
Roche's Floodlight MS app mines 'hidden' data to advance disease mapping
Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling
Abbott launches 3-minute, in-office A1c blood test for diagnosing diabetes
News of note-GSK-backed lung map reveals
asthma targets; a new way to combat the common cold
jUNE 17, 2019 | ArleneWeintraub | GSK-backed lung map reveals new targets in asthma
Researchers from the Wellcome Sanger Institute, with support from GlaxoSmithKline and others, have produced a comprehensive map of the human lung that reveals key differences between normal and asthmatic patients. Using samples from 17 people, the team analyzed 36,000 different cells from the lungs and nasal passages, tracking the specific genes that were active in each one.
Making it personal: How genetic technologies are changing the face of medicine
June 14, 2019 | The age of one-size-fits-all medicine is fading. Taking its place is an era of personalized medicine - the practice of tailoring disease prevention, diagnosis, and treatment to patients as individuals. Many cancers, for example, are resistant to conventional therapies but respond to medications that target specific cancer-causing genetic mutations.
The brain consumes half of a child's energy -- and that could matter for weight gain
June 17, 2019 | Northwestern University | A new study proposes that variation in the energy needs of brain development across kids -- in terms of the timing, intensity and duration of energy use -- could influence patterns of energy expenditure and weight gain.
June 15, 2019 | Kelly Crowe | CBC News | What happens when scientists throw open their notebooks, publishing failures and raw data in real time? Getting scooped by a competing researcher is one of a scientist's biggest fears. And some of the most important discoveries in medical history have been tainted by competitive controversy.
Can scientists learn to bypass superbugs' drug resistance?
June 17, 2019 | Maria Cohut |
When bacteria become resistant to antibiotic treatments, this poses an important threat to health, as infections become very difficult - and sometimes impossible - to treat. But could a new strategy successfully identify the weak point of superbugs?
The SuperclusterProject Manager is a collaborative member of the Sectors team and works seamlessly across the organization. Reporting to the CSO & VP Sectors, you are the main point of contact at Genome BC for approved Canada's Digital Technology Supercluster (Supercluster) projects and you are responsible for launching, developing and coordinating activities on projects funded under this initiative. You will also engage external stakeholders to catalyze partnerships, and work with internal colleagues in the Health and Agrifood and Natural Resources sectors, and in all departments that are relevant to these projects and are consistent with the Genome BC's mandate.
The Data Manager (DM) represents a core functional role for the department and supports the organization and conduct of data management activities for which the department assumes the responsibility for study management. Under the direction of the Data Management Operations Lead, the DM will execute and support the implementation of data management activities to help ensure data management service delivery for studies undertaken by the CTN and CHÉOS is successful.
The Senior Regulatory Affairs Specialist role at STEMCELL assists in the development and implementation of strategies to meet compliance to applicable regulations. It gives the opportunity to exercise independent judgment in evaluating complex problems and applying current methodologies and practices to resolve identified issues. STEMCELL is a dynamic workplace that pursues cutting edge technologies and practices which translates to this role managing complex sources of data that require in-depth critical thinking and reviewing the impact to the department and organization.
The Scientist within the Contract Assay Services (CAS) Department is responsible for working with a team on client driven projects that support the application of STEMCELL products. The position primarily focuses on client projects at all levels including following standard operating procedures (SOPs), writing new standard operating procedures where required, following quality documentation practices, preparing and executing client driven studies including data analysis and preparation of client reports.
This position provides operational support to the Centre for Health Evaluation and Outcome Sciences (CHÉOS) and the CIHR Canadian HIV Trials Network (CTN) National Centre, including human resources (HR), administrative, facilities, events, communications, and special projects assistance. The Program Assistant works closely with CHÉOS/CTN research and administrative staff, as well as CHÉOS faculty. The incumbent will liaise with various partners including Providence Health Care (PHC), Providence Health Care Research Institute (PHCRI), St. Paul's Hospital, research centres under the PHCRI umbrella, Health Shared Services BC (HSSBC), and the University of British Columbia (UBC).
member
NEWS
IN THIS ISSUE
